| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, International Markets | EVP, Growth Markets Commercial
1 company
Nazzi Gianfranco serves as an EVP, International Markets at TEVA. Across recent SEC filings that breaks down to 0 buys and 16 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 512 | $16.88 | $8,644.81 | -6.1% | |
| Sep 18, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 1,379 | $23.69 | $32,669.89 | -16.4% | |
| Mar 19, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 457 | $17.89 | $8,176.64 | -7.4% | |
| Mar 12, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 461 | $19.50 | $8,988.58 | -8.0% |